Fluidigm (FLDM) Completes $250 Million Strategic Capital Infusion and Changes Name to Standard BioTools Inc. Apr 4, 2022 05:32PM
Fluidigm Completes $250 Million Strategic Capital Infusion and Changes Name to Standard BioTools Inc. Apr 4, 2022 05:30PM
Fluidigm (FLDM) Announces Stockholders Approve $250 Million Strategic Capital Infusion Apr 1, 2022 04:06PM
Fluidigm Stockholders Approve $250 Million Strategic Capital Infusion Apr 1, 2022 04:05PM
Fluidigm (FLDM) Announces Support Agreement with Caligan Partners Related to $250 Million Strategic Capital Infusion by Casdin Capital and Viking Global Mar 29, 2022 09:30AM


Mar 29, 2022 09:29AM Fluidigm Announces Support Agreement with Caligan Partners Related to $250 Million Strategic Capital Infusion by Casdin Capital and Viking Global
Mar 28, 2022 08:33AM Fluidigm (FLDM) Highlights the Strategic Capital Infusion by Casdin Capital and Viking Global as the Only Actionable Financing Solution
Mar 28, 2022 08:30AM Fluidigm Highlights the Strategic Capital Infusion by Casdin Capital and Viking Global as the Only Actionable Financing Solution
Mar 25, 2022 04:00PM Fluidigm Adjourns Special Meeting of Stockholders Until April 1, 2022
Mar 21, 2022 08:00AM Fluidigm Urges Stockholders to Vote “FOR” ALL Proposals Related to $250 Million Strategic Capital Infusion TODAY
Mar 17, 2022 05:58PM Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Fluidigm Stockholders Vote “FOR” ALL Proposals Related to $250 Million Strategic Capital Infusion
Feb 18, 2022 05:37AM Fluidigm (FLDM) Reports Q4 Revenue of $38.3M, Net Loss of $0.8M
Feb 17, 2022 05:43PM Fluidigm Announces Fourth Quarter and Full Year 2021 Financial Results 
Feb 14, 2022 06:11AM Fluidigm (FLDM) Files Prelim Proxy Statement for Proposed $250M Investment from Casdin Capital and Viking Global Investors
Feb 14, 2022 06:10AM Fluidigm Files Preliminary Proxy Statement in Connection with Proposed Strategic Capital Infusion from Casdin Capital and Viking Global Investors
Jan 24, 2022 08:34AM Fluidigm (FLDM) Announces $250 Million Strategic Capital Infusion from Casdin Capital and Viking Global Investors and Rebranding to Standard BioTools Inc.
Jan 24, 2022 08:30AM Fluidigm Announces $250 Million Strategic Capital Infusion from Casdin Capital and Viking Global Investors and Rebranding to Standard BioTools Inc.